MUKKAMukka Proteins Limited
FMCG · Packaged Foods · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Mukka Proteins Limited manufactures and sells fish protein products in India. The company offers fish meal, oil, and soluble paste; and ento meal, oil, and soil. It also provides insect meal, oil, and compost; and humic acid. The company's products are used for aqua feed, poultry feed, pet feed, EPADHA extraction, animal feed, soap manufacture, leather tanneries, and paint industries. It also exports its products to Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, the Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan, and Vietnam. The company was formerly known as Mukka Sea Food Industries Limited and changed its name to Mukka Proteins Limited in August 2021. The company was founded in 1960 and is based in Mangalore, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on MUKKA — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why buy
- • Revenue growth: 186.7% YoY
- • Profit growth: 1160.0% YoY
- • Promoter holding: 74.5%
- • RSI: 72
- • MACD: bullish
- • Price vs EMA21: above
Bull case
- • Revenue growth: 186.7% YoY
- • Profit growth: 1160.0% YoY
- • Promoter holding: 74.5%
- • RSI: 72
Bear case
- • ROE: 10.4%
- • ROCE: 7.7%
- • Sector momentum: sector -0.6% (1m)
- • Max drawdown (1y): 36%
Key risks
- • ROE: 10.4%
- • ROCE: 7.7%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹1.86). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.